Who Should Be The Next FDA Commissioner? David Kessler Weighs In
This article was originally published in The Gray Sheet
Executive Summary
Former FDA Commissioner David Kessler has some ideas about the kind of person President-elect Barack Obama should pick to succeed Andrew von Eschenbach at FDA
You may also be interested in...
Waxman’s Legislative Powers On The Rise: How Much Will Fall On MedTech?
Rep. Henry Waxman's new perch atop the House Energy and Commerce Committee gives the aggressive lawmaker at least as much leverage as he has recently enjoyed on the investigative front, but more authority to follow through with legislation
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.